300 Participants Needed

EDRM for Autism

MM
AS
Overseen ByAllison Schwartz, PhD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Emory University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new method for early autism diagnosis in young children at high risk. The focus is on developing and evaluating a plan to identify autism sooner, using tools like parent surveys and clinician assessments. This approach is called the Early Diagnostic Response Model (EDRM), also known as the Telehealth-based Autism Diagnostic Protocol or Autism Early Detection Model. Suitable participants are children aged 16-30 months who have been flagged as high-risk for autism through the M-CHAT-R screening and are referred by specific early intervention programs in Georgia. Parents must have basic English skills, internet access, and their child should regularly hear English at home or in care settings. As an unphased trial, this study offers families the chance to contribute to groundbreaking research that could lead to earlier autism diagnosis and intervention.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What prior data suggests that this diagnostic protocol is safe for children?

Research has shown that the Early Diagnostic Response Model (EDRM) aims to simplify diagnosing autism in young children. As EDRM is a diagnostic tool rather than a treatment or medication, specific safety data is limited.

Studies have found that using machine learning and telehealth for autism diagnosis is generally safe, with no reports of negative side effects. The process typically involves answering questions and completing assessments online.

Since EDRM focuses on early autism diagnosis, it does not involve drugs or physical treatments. Safety concerns are minimal, as it primarily involves gathering information through surveys and assessments.12345

Why are researchers excited about this trial?

Researchers are excited about the Early Diagnostic Response Model (EDRM) for autism because it aims to streamline the diagnostic process for young children, potentially leading to earlier intervention. Unlike traditional methods that can be lengthy and fragmented, EDRM integrates a comprehensive survey and targeted clinician assessment to deliver a faster diagnosis. This approach could help address the critical need for timely identification of autism, allowing families to access support and resources sooner.

What evidence suggests that the Early Diagnostic Response Model (EDRM) is effective for autism?

Research shows that the Early Diagnostic Response Model (EDRM) for autism, which participants in this trial will receive, aims to improve autism diagnosis in young children. Studies have found that advanced tools like automated machine learning can make diagnosing autism spectrum disorder (ASD) faster and more accurate. Early detection models using electronic health records have been tested and effectively predict autism in high-risk toddlers. Initial findings suggest that this approach can help identify autism sooner, allowing for quicker interventions. Online assessment tools are also being tested to support accurate and timely diagnoses.16789

Who Is on the Research Team?

AS

Allison Schwartz, PhD

Principal Investigator

Emory University

Are You a Good Fit for This Trial?

This trial is for families with children aged 16-30 months at risk for autism, referred by specific BCW districts. Participants need internet access, exposure to English, and basic English skills. Children must score ≥8 on the MCHAT-R and be referred by 33 months of age.

Inclusion Criteria

My child is 16-30 months old, scored ≥8 on the MCHAT-R, and was referred to the clinic by 33 months.
Referring BCW provider must be one of the three targeted BCW districts participating in this pilot study.
Parent/Guardian needs to have basic English proficiency
See 3 more

Exclusion Criteria

Non-English speakers will be excluded from participation due to the high correlation between verbal language abilities and social communication and social interaction (SCI) abilities as part of the DSM-5-TR autism criteria.
Families making self-referrals to the EAC or referrals outside of the targeted BCW districts will be excluded from recruitment for this study.
My child is not older than 33 months.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Assessment

Families with children between 16-33 months complete developmental history surveys and questionnaires, followed by an autism assessment and feedback session.

Up to 12 weeks
1 in-person visit, telehealth sessions

Follow-up

Participants are monitored for satisfaction and effectiveness of the EDRM assessment.

3 months
Satisfaction surveys administered

Evaluation Completion

Final summary report sent to families and analysis of the number of families who received ASD evaluation.

Until study completion (approximately 1 year)

What Are the Treatments Tested in This Trial?

Interventions

  • Early Diagnostic Response Model (EDRM)
Trial Overview The EDRM protocol is being tested to see if it's effective in diagnosing autism early in kids identified as high-risk in a public health service program. The study will collect data before and after implementing EDRM to assess its success.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Families with children enrolled in BCW with suspected diagnosis of autismExperimental Treatment1 Intervention

Early Diagnostic Response Model (EDRM) is already approved in United States for the following indications:

🇺🇸
Approved in United States as Early Diagnostic Response Model (EDRM) for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

Georgia Department of Public Health

Collaborator

Trials
2
Recruited
1,400+

Published Research Related to This Trial

Telemedicine shows promise as an effective alternative for screening and diagnosing Autism Spectrum Disorder (ASD), potentially reducing the long wait times parents currently face for assessments.
A systematic review of 26 studies revealed that telemedicine applications for ASD had varying sensitivity (0.70 to 1) and specificity (0.38 to 1), indicating that while some tools are effective, more rigorous studies with larger sample sizes are needed to fully evaluate their reliability and effectiveness.
A systematic review of telehealth screening, assessment, and diagnosis of autism spectrum disorder.Liu, M., Ma, Z.[2022]
A study using electronic health records from 45,080 children found that an automated model for early autism detection achieved 45.5% sensitivity and 23.0% positive predictive value (PPV) at 30 days old, indicating a promising start for early identification.
By age 1 year, the model's sensitivity improved to 59.8% with a PPV of 17.6%, suggesting that integrating this model with caregiver surveys could enhance early screening accuracy for autism.
Predictive Value of Early Autism Detection Models Based on Electronic Health Record Data Collected Before Age 1 Year.Engelhard, MM., Henao, R., Berchuck, SI., et al.[2023]
Telehealth methods, including real-time video conferencing and the Store-and-Forward approach, show promise in diagnosing Autism Spectrum Disorder (ASD) with high agreement compared to traditional face-to-face methods, based on a review of 10 studies.
Families and clinicians reported high satisfaction with telehealth assessments, indicating that these methods could improve access to ASD diagnosis, especially for individuals with clear autism traits, though further research with larger sample sizes is needed.
Use of telehealth for facilitating the diagnostic assessment of Autism Spectrum Disorder (ASD): A scoping review.Alfuraydan, M., Croxall, J., Hurt, L., et al.[2020]

Citations

NCT05419895 | Early Diagnostic Response Model (EDRM)The objective of this study is to develop, pilot, and evaluate a diagnostic protocol to assess high-risk toddlers for autism spectrum disorder (ASD) diagnosis ...
Early Detection of Autism Spectrum Disorder Through ...This research proposes leveraging automated machine learning (AUTOML) to streamline the diagnostic process and enhance its accuracy. Methods: In ...
EDRM for Autism · Recruiting Participants for Clinical Trial ...This trial is testing a new method to diagnose autism in young children using online tools. It focuses on families with high-risk toddlers.
Predictive Value of Early Autism Detection Models Based ...This diagnostic study evaluates the accuracy of early autism detection models based on electronic health record data collected before age 1 ...
Tele-assessment of young children referred for autism ...The present study examined clinical characteristics and diagnostic outcome for young children receiving autism spectrum disorder tele-assessment during the ...
Early Detection of Autism Spectrum Disorder Through ...This research proposes leveraging automated machine learning (AUTOML) to streamline the diagnostic process and enhance its accuracy. Methods: In this study, by ...
Accelerating autism spectrum disorder care: A rapid review ...Data-driven methods enable early, personalized, and accurate ASD diagnosis and interventions. •. Ethical use, privacy, and equitable access are vital for ...
Telehealth diagnosis of autism spectrum disorder through ...The purpose of this case series is to provide examples of three different approaches to ASD differential diagnostic services via telehealth that we have taken ...
Early diagnosis of autism across developmental stages ...This study introduces a robust and interpretable machine learning framework to diagnose ASD using questionnaire data.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security